Back
Pliant Therapeutics, Inc. 10K Form
Sell
32
PLRX
Pliant Therapeutics, Inc.
Last Price:
$1.35
Seasonality Move:
-17.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PLRX News And Ratings
See the #1 stock for the next 7 days that we like better than PLRX
PLRX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-17.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.95 |
| Price / Book: | 0.47 |
Profitability
| EPS (TTM): | -2.43480 |
|---|---|
| Net Income (TTM): | $-149.3M |
| Gross Margin: | $-1.7M |
| Return on Equity: | -64.22% |
| Return on Assets: | -48.22% |
Pliant Therapeutics, Inc. Earnings Forecast
Key Pliant Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Pliant Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PLRX |
| CUSIP: | 729139 |
| Website: | pliantrx.com |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 12 |
| Quick Ratio: | 11.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PLRX Technical Analysis vs Fundamental Analysis
Sell
32
Pliant Therapeutics, Inc. (PLRX)
is a Sell
Is Pliant Therapeutics, Inc. a Buy or a Sell?
-
Pliant Therapeutics, Inc. stock is rated a SellThe current Pliant Therapeutics, Inc. [PLRX] share price is $1.35. The Score for PLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.